Perspectives of Acute Myeloid Leukemia Patients During Initial Diagnosis

Summary

Researchers at the University of Calgary would like to know what people who are recently diagnosed with acute myeloid leukemia (AML) understand about their disease when first diagnosed. When people are diagnosed with AML, they receive a large amount of information upfront. During diagnosis people need to make treatment related decisions quickly. The goal of this study is to understand how people with AML understand their diagnosis and make treatment related decisions. Using this information, we may improve patient education and support strategies

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Accepts healthy participants: Yes

Inclusion criteria:

Who is eligible:
1. Adults aged 18 or older who have been diagnosed with acute myeloid leukemia (AML) cancer within the last six months and have undergone only one type of treatment for their AML.
2. Must be able to speak and read English and capable of providing informed consent.
3. Must be willing to participate in a one on one interview for approximately 60-90 minutes.
4. Must be able to engage with interview team via telephone or electronic platform, or in person if residing in Calgary.

Exclusion criteria:

Who is NOT eligible:
1. Pregnant women.
2. People who cannot speak English.
3. People who cannot provide informed consent.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Additional information

Contact information

1. Hematologist Referral or 2. Camille Piquette (Study Staff) Camille.piquette@ucalgary.ca 403-220-6198

Principal investigator:

Colleen Cuthbert

Clinical trial:

No

REB-ID:

HREBA.CC-23-0232

External links

Cuthbert Lab